Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.222\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cn1c(SCC(=O)NC2CCCC2)nnc1C(F)(F)F
b. CC(=NC1CCCC1)c1c(C)[nH]n(-c2nc3ccccc3s2)c1=O
c. O=C(Nc1ccc(Cl)cc1C(=O)N1CCCCC1)c1ccco1
Answer: b. CC(=NC1CCCC1)c1c(C)[nH]n(-c2nc3ccccc3s2)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=NC1CCCC1)c1c(C)[nH]n(-c2nc3ccccc3s2)c1=O
CC(=NC1CCCC1)c1c(C)[nH]n(-c2nc3ccccc3s2)c1=O
2-(1,3-benzothiazol-2-yl)-4-(N-cyclopentyl-C-methylcarbonimidoyl)-5-methyl-1H-pyrazol-3-one